Colorectal cancer migration and invasion initiated by microRNA-106a

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Feng, Bo ^a,b,c   Dong, Tao Tao ^d   Wang, Lin Lin ^a   Zhou, Hou Min ^a,b,c   Zhao, Hong Chao ^a,b,c   Dong, Feng ^a   Zheng, Min Hua ^a,b,c  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Shanghai Institute of Digestive Surgery   (China)

^c Shanghai Minimally Invasive Surgery Center   (China)

^d SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 106A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER CONTROL; CANCER GROWTH; CANCER INVASION; CELL MIGRATION; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ACTIVITY; GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PHENOTYPE; PRIMARY TUMOR; TARGET CELL; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2 GENE;

BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HT29 CELLS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS, EXPERIMENTAL; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSPLANTATION, HETEROLOGOUS;

EID: 84865097993     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043452     Document Type: Article

References (37)

1. Gupta GP, Massague J, ((2006)) Cancer metastasis: building a framework. Cell 127:: 679--695.
2. Fidler IJ, ((2003)) The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3:: 453--458.
3. Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, et al. ((2000)) The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2:: 84--89.
4. Bolos V, Peinado H, Perez-Moreno MA, Fraga MF, Esteller M, et al. ((2003)) The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J Cell Sci 116:: 499--511.
5. Hartwell KA, Muir B, Reinhardt F, Carpenter AE, Sgroi DC, et al. ((2006)) The Spemann organizer gene, Goosecoid, promotes tumor metastasis. Proc Natl Acad Sci U S A 103:: 18969--18974.
6. Mani SA, Yang J, Brooks M, Schwaninger G, Zhou A, et al. ((2007)) Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc Natl Acad Sci U S A 104:: 10069--10074.
7. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, et al. ((2004)) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117:: 927--939.
8. Bartel DP, ((2009)) MicroRNAs: target recognition and regulatory functions. Cell 136:: 215--233.
9. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, et al. ((2004)) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101:: 2999--3004.
10. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, et al. ((2005)) A microRNA polycistron as a potential human oncogene. Nature 435:: 828--833.
11. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, et al. ((2005)) RAS is regulated by the let-7 microRNA family. Cell 120:: 635--647.
12. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. ((2005)) MicroRNA expression profiles classify human cancers. Nature 435:: 834--838.
13. Roldo C, Missiaglia E, Hagan JP, Falconi M, Capelli P, et al. ((2006)) MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 24:: 4677--4684.
14. Ventura A, Jacks T, ((2009)) MicroRNAs and cancer: short RNAs go a long way. Cell 136:: 586--591.
15. Calin GA, Croce CM, ((2006)) MicroRNA signatures in human cancers. Nat Rev Cancer 6:: 857--866.
16. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, et al. ((2008)) MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299:: 425--436.
17. Diaz R, Silva J, Garcia JM, Lorenzo Y, Garcia V, et al. ((2008)) Deregulated expression of miR-106a predicts survival in human colon cancer patients. Genes Chromosomes Cancer 47:: 794--802.
18. Link A, Balaguer F, Shen Y, Nagasaka T, Lozano JJ, et al. ((2010)) Fecal MicroRNAs as novel biomarkers for colon cancer screening. Cancer Epidemiol Biomarkers Prev 19:: 1766--1774.
19. Meister G, Landthaler M, Dorsett Y, Tuschl T, ((2004)) Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA 10:: 544--550.
20. Chen CZ, Li L, Lodish HF, Bartel DP, ((2004)) MicroRNAs modulate hematopoietic lineage differentiation. Science 303:: 83--86.
21. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, et al. ((2007)) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 27:: 91--105.
22. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, et al. ((2005)) Combinatorial microRNA target predictions. Nat Genet 37:: 495--500.
23. Cheng N, Chytil A, Shyr Y, Joly A, Moses HL, ((2008)) Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion. Mol Cancer Res 6:: 1521--1533.
24. Hirai Y, Utsugi K, Takeshima N, Kawamata Y, Furuta R, et al. ((2004)) Putative gene loci associated with carcinogenesis and metastasis of endocervical adenocarcinomas of uterus determined by conventional and array-based CGH. Am J Obstet Gynecol 191:: 1173--1182.
25. Mamiya T, Yamazaki K, Masugi Y, Mori T, Effendi K, et al. ((2010)) Reduced transforming growth factor-beta receptor II expression in hepatocellular carcinoma correlates with intrahepatic metastasis. Lab Invest 90:: 1339--1345.
26. Sathyanarayana UG, Maruyama R, Padar A, Suzuki M, Bondaruk J, et al. ((2004)) Molecular detection of noninvasive and invasive bladder tumor tissues and exfoliated cells by aberrant promoter methylation of laminin-5 encoding genes. Cancer Res 64:: 1425--1430.
27. Tan AR, Alexe G, Reiss M, ((2009)) Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer? Breast Cancer Res Treat 115:: 453--495.
28. Borczuk AC, Sole M, Lu P, Chen J, Wilgus ML, et al. ((2011)) Progression of human bronchioloalveolar carcinoma to invasive adenocarcinoma is modeled in a transgenic mouse model of K-ras-induced lung cancer by loss of the TGF-beta type II receptor. Cancer Res 71:: 6665--6675.
29. Spaderna S, Schmalhofer O, Wahlbuhl M, Dimmler A, Bauer K, et al. ((2008)) The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. Cancer Res 68:: 537--544.
30. Siegel PM, Massague J, ((2003)) Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer 3:: 807--821.
31. MacKay SL, Auffenberg T, Tannahill CL, Ksontini R, Josephs MD, et al. ((1998)) Transfection of the type II TGF-beta receptor into colon cancer cells increases receptor expression, inhibits cell growth, and reduces the malignant phenotype. Ann Surg 227:: 781--789.
32. Dews M, Fox JL, Hultine S, Sundaram P, Wang W, et al. ((2010)) The myc-miR-17~92 axis blunts TGF{beta} signaling and production of multiple TGF{beta}-dependent antiangiogenic factors. Cancer Res 70:: 8233--8246.
33. Stewart SA, Dykxhoorn DM, Palliser D, Mizuno H, Yu EY, et al. ((2003)) Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 9:: 493--501.
34. Sayan AE, Stanford R, Vickery R, Grigorenko E, Diesch J, et al. ((2012)) Fra-1 controls motility of bladder cancer cells via transcriptional upregulation of the receptor tyrosine kinase AXL. Oncogene 31:: 1493--1503.
35. Dong TT, Zhou HM, Wang LL, Feng B, Lv B, et al. ((2011)) Salinomycin selectively targets 'CD133+' cell subpopulations and decreases malignant traits in colorectal cancer lines. Ann Surg Oncol 18:: 1797--1804.
36. Cheng AM, Byrom MW, Shelton J, Ford LP, ((2005)) Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 33:: 1290--1297.
37. Edge SB, Compton CC, ((2010)) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17:: 1471--1474.